Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 105, Issue 11, Pages 1496-1502
Publisher
Wiley
Online
2014-09-13
DOI
10.1111/cas.12529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3
- (2013) S. Z. Usmani et al. BLOOD
- Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma
- (2013) Aiko Nobusawa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG
- (2012) Atsushi Isoda et al. ANNALS OF NUCLEAR MEDICINE
- Darwinian evolution and tiding clones in multiple myeloma
- (2012) N. J. Bahlis BLOOD
- Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
- (2012) K Kaira et al. BRITISH JOURNAL OF CANCER
- Transport of 3-Fluoro-L- -Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET
- (2012) P. Wiriyasermkul et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
- (2011) E. Zamagni et al. BLOOD
- Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study
- (2011) Irene M Ghobrial et al. LANCET ONCOLOGY
- Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
- (2011) P Kapoor et al. LEUKEMIA
- High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions
- (2011) Masaaki Ichinoe et al. PATHOLOGY INTERNATIONAL
- Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
- (2010) D. Hose et al. HAEMATOLOGICA
- Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas
- (2010) Shuichi Okubo et al. JOURNAL OF NEURO-ONCOLOGY
- Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
- (2009) P. Kapoor et al. BLOOD
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
- (2008) K Kaira et al. BRITISH JOURNAL OF CANCER
- l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
- (2008) Kyoichi Kaira et al. CANCER SCIENCE
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now